SODIUM VALPROATE AND CLONAZEPAM FOR TREATMENT-RESISTANT PANIC DISORDER

被引：0
|
作者：
ONTIVEROS, A [1 ]
FONTAINE, R [1 ]
机构：
[1] UNIV MONTREAL,LOUIS H LAFONTAINE HOSP,RES CTR,7331 HOCHELAGA,MONTREAL H1N 3M5,QUEBEC,CANADA
来源：
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 1992年 / 17卷 / 02期
关键词：
PANIC DISORDER; AGORAPHOBIA; CLONAZEPAM; SODIUM VALPROATE;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Sodium valproate (VA) and clonazepam (CLZ) were combined in the treatment of 4 patients with panic disorders (PD) who were resistant to several antipanic drug treatments. A significant improvement was found in the symptomatology of these patients, but relapses occurred when CLZ dosage was reduced. A potentiation of the GABAergic properties of VA and clonazepam is posulated. This combined treatment could be advantageous for some treatment-resistant PD patients but needs to be studied further.
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [31] CLONAZEPAM IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER ASSOCIATED WITH PANIC DISORDER IN ONE PATIENT
    BODKIN, JA
    WHITE, K
    JOURNAL OF CLINICAL PSYCHIATRY, 1989, 50 (07) : 265 - 266
  • [32] Pivotal studies of clonazepam in panic disorder
    Davidson, JRT
    Moroz, G
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (02) : 169 - 174
  • [33] Naturalistic study of clonazepam in panic disorder
    Worthington, JJ
    Pollack, MH
    Moroz, G
    Otto, MW
    McLean, RYS
    Rosenbaum, JF
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 606 - 606
  • [34] COMPARATIVE-STUDY OF SODIUM VALPROATE AND CLONAZEPAM IN THE TREATMENT OF ABSENCE SEIZURES
    MIURA, H
    MINAGAWA, K
    YAGI, J
    BRAIN & DEVELOPMENT, 1984, 6 (04): : 419 - 420
  • [35] Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient
    Zulfarina, Mohamed S.
    Syarifah-Noratiqah, Syed-Badrul
    Nazrun, Shuid A.
    Sharif, Razinah
    Naina-Mohamed, Isa
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2019, 17 (02) : 145 - 154
  • [36] Double-blind clonazepam vs placebo in panic disorder treatment
    Valença, AM
    Nardi, AE
    Nascimento, I
    Mezzasalma, MA
    Lopes, FL
    Zin, W
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (04) : 1025 - 1029
  • [37] INTERACTION BETWEEN CLONAZEPAM AND SODIUM VALPROATE - REPLY
    BROWNE, TR
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (12): : 679 - 679
  • [38] Randomized, Open Naturalistic, Acute Treatment of Panic Disorder With Clonazepam or Paroxetine
    Nardi, Antonio E.
    Valenca, Alexandre M.
    Freire, Rafael C.
    Amrein, Roman
    Sardinha, Aline
    Levitan, Michelle N.
    Nascimento, Isabella
    de-Melo-Neto, Valfrido L.
    King, Anna L.
    Silva, Adriana C. de O. e
    Veras, Andre B.
    Dias, Gisele P.
    Soares-Filho, Gastao L.
    da Costa, Rafael T.
    Mezzasalma, Marco A.
    de Carvalho, Marcele R.
    de Cerqueira, Ana C.
    Hallak, Jaime E.
    Crippa, Jose A.
    Versiani, Marcio
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (02) : 259 - 261
  • [39] Clonazepam and milnacipran in the treatment of patients with panic disorder and comorbid major depression
    Cia, Alfredo H.
    Brizuela, Julio A.
    Cascardo, Enzo
    Varela, Maria F.
    PRIMARY CARE & COMMUNITY PSYCHIATRY, 2006, 11 (02) : 51 - 56
  • [40] EFFECTS OF TREATMENT WITH IMIPRAMINE AND CLONAZEPAM ON AN ANIMAL-MODEL OF PANIC DISORDER
    SHEKHAR, A
    BIOLOGICAL PSYCHIATRY, 1994, 36 (11) : 748 - 758
12345